Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar;17(2):325-327.
doi: 10.1007/s11739-021-02886-7. Epub 2022 Jan 27.

COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge

Janet Sultana  1   2 , Grazia Caci  3 , Giulia Hyeraci  4 , Luciana Albano #  5 , Vincenza Gianfredi #  6   7
Affiliations
Comment

COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge

Janet Sultana et al. Intern Emerg Med. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

G.H. is employed by ARS, a public health agency that conducts or participates in pharmacoepidemiology studies compliant with the ENCePP Code of Conduct; the budget of ARS is partially sustained by such studies. All other authors declare no conflict of interest.

Comment on

References

    1. Ponticelli D, Madotto F, Conti S, et al. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up. Intern Emerg Med. 2021 doi: 10.1007/s11739-021-02857-y. - DOI - PMC - PubMed
    1. Vigezzi GP, Lume A, Minerva M et al (2021) Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital. Acta Biomed 92(S6): e2021450. 10.23750/abm.v92iS6.12217 - PMC - PubMed
    1. Gianfredi V, Minerva M, Casu G et al (2021) Immediate adverse events following COVID-19 immunization. A cross-sectional study of 314,664 Italian subjects. Acta Biomed. 92(S6):e2021487. 10.23750/abm.v92iS6.12365 - PMC - PubMed
    1. Ponticelli D, Antonazzo IC, Caci G, et al. Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months. J Travel Med. 2021 doi: 10.1093/jtm/taab173. - DOI - PubMed
    1. Krause PR, Fleming TR, Longini IR, et al. SARS-CoV-2 Variants and Vaccines. N Engl J Med. 2021;385:179–186. doi: 10.1056/NEJMsr2105280. - DOI - PMC - PubMed

LinkOut - more resources